FDA Grants Emergency Authorization To Eli Lilly's COVID Treatment

Watch VideoBamlanivimab the first FDA emergency-approved drug for mild to moderate COVID-19 patients, is meant to stop this from happening. 

The drug imitates the immune system’s response to the virus. Antibodies are made in a lab and given to COVID patients via IV early in the illness. It takes an hour to administer it,...